226-240 of 981
Understanding the Pathophysiology Behind ATTR-CM
Heart MattersUnderstanding the Pathophysiology Behind ATTR-CM
Frederick Ruberg, MD
Cost-Effectiveness of Universal vs. Selective Screening for ATTR-CM in HFpEF Patients
Heart MattersCost-Effectiveness of Universal vs. Selective Screening for ATTR-CM in HFpEF Patients
Kibum Kim, PhD
ATTR-CM Screening: How Economic Factors Can Impact Care
Heart MattersATTR-CM Screening: How Economic Factors Can Impact Care
Kibum Kim, PhD
Patient Case: ATTRwt-CM Discovered Decades After Heart Transplant
Heart MattersPatient Case: ATTRwt-CM Discovered Decades After Heart Transplant
Lily Stern, MD
Silent Brain Damage in ATTR-CM: Exploring Neurological Impacts
Spotlight On ATTR-CMSilent Brain Damage in ATTR-CM: Exploring Neurological Impacts
Vutrisiran for ATTR-CM: Exploring an RNAi Therapeutic
Spotlight On ATTR-CMVutrisiran for ATTR-CM: Exploring an RNAi Therapeutic
- advertisement
Unveiling the Link Between Dermatological and Cardiovascular Health
Clinician's RoundtableUnveiling the Link Between Dermatological and Cardiovascular Health
The AMA MAP™ Hypertension Program in Action: Insights from Grace Health
Perspectives with the AMAThe AMA MAP™ Hypertension Program in Action: Insights from Grace Health
Charles Turck, PharmD, BCPS, BCCCP
Emily Reidenbach, PharmD, MBA
Examining CVD in Lupus: Insights from a Diverse Population-Based Registry
Living RheumExamining CVD in Lupus: Insights from a Diverse Population-Based Registry
Peter Izmirly, MD
Assessing the AMA MAP™ Hypertension Program’s Impact at Rush University Medical Center
Perspectives with the AMAAssessing the AMA MAP™ Hypertension Program’s Impact at Rush University Medical Center
Gates B. Colbert, MD
Michael Cui, MD, MBA, MS
Heart Health Alert: Cardiac Risks for Women Under 50
What Your Patients Are Talking AboutHeart Health Alert: Cardiac Risks for Women Under 50
Brian P. McDonough, MD, FAAFP
Implementing the AMA MAP™ Hypertension Program: A Clinician's Experience
Perspectives with the AMAImplementing the AMA MAP™ Hypertension Program: A Clinician's Experience
Brian P. McDonough, MD, FAAFP
Willie Lawrence, MD
- advertisement
AI in Nuclear Medicine: Improvements in the Field
Project Oncology®AI in Nuclear Medicine: Improvements in the Field
Chi Liu, PhD
Beyond the Surface: The Impact of Psoriasis on Cardiovascular Health
Spotlight on PsoriasisBeyond the Surface: The Impact of Psoriasis on Cardiovascular Health
John Barbieri, MD, MBA, FAAD
How Artificial Sweeteners Could Be Linked to Heart Disease
Heart MattersHow Artificial Sweeteners Could Be Linked to Heart Disease
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Wilson Tang, MD